Request Deal Involvement

Soleus Capital led a $96m Series B funding round in Antios Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Pryor Cashman

legal advisors

Pryor Cashman

Dechert

legal advisors

Dechert

Burns McClellan

pr advisors

Burns McClellan

or

Principals

AMZAK CAPITAL MANAGEMENT

bidder

AMZAK CAPITAL MANAGEMENT

SOLEUS CAPITAL

bidder

SOLEUS CAPITAL

AISLING CAPITAL LLC

bidder

AISLING CAPITAL LLC

ALTIUM CAPITAL

bidder

ALTIUM CAPITAL

ANTIOS THERAPEUTICS

target

ANTIOS THERAPEUTICS

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

ADAGE CAPITAL MANAGEMENT

bidder

ADAGE CAPITAL MANAGEMENT

PONTIFAX LIMITED

bidder

PONTIFAX LIMITED

GRANITE POINT CAPITAL

bidder

GRANITE POINT CAPITAL

LP FIRST CAPITAL

bidder

LP FIRST CAPITAL

LIFESCI VENTURE PARTNERS

bidder

LIFESCI VENTURE PARTNERS

LUMIRA VENTURES

bidder

LUMIRA VENTURES

CAM CAPITAL

bidder

CAM CAPITAL

DELOS CAPITAL

bidder

DELOS CAPITAL

DOMAIN ASSOCIATES LLC

bidder

DOMAIN ASSOCIATES LLC

SIXTY DEGREE CAPITAL

bidder

SIXTY DEGREE CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Soleus Capital led a $96m Series B funding round in Antios Therapeutics.